Asian Spectator

Men's Weekly

.

Global Talent Summit Week Returns to Hong Kong March 18–19, Featuring Nobel Laureate, President of Peking University and SenseTime Co-founder

Focusing on talent ecosystem in the AI-era, reinforcing Hong Kong’s position as Asia’s Premier International talent hubHONG KONG SAR - Media OutReach Newswire - 4 March 2026 - The Labour ...

TCL Brings Newest Intelligent Processor to IFA 2020 with Theme...

HONG KONG, Aug. 24, 2020/PRNewswire-AsiaNet/-- - ome experience TCL's AIxIoT lifestyle with intelligent advancement, impressive overview of smart connected home devices and highly anticipate...

Mini LEDs, Big Picture: Philips 65-inch MiniLED TV Launches in Malaysia

Brilliant Mini LED display, 4-sided Ambilight, and total UHD qualityPETALING JAYA, MALAYSIA - Media OutReach - 30 May 2022 - Mini LED Technology brings amazing deep blacks and vibrant colou...

Appian Connected Claims Solution Available in AWS Marketplace

MCLEAN, Virginia, Dec. 1, 2020 /PRNewswire-AsiaNet/-- --Configurable, low-code Appian Connected Claims can be deployed in weeks to improve customer experience, optimize processes, and compli...

Tech Innovation Drives Development of Chengdu-Chongqing Econom...

CHENGDU, China, March 11, 2021 /PRNewswire-AsiaNet/ -- News provided by China Report: Located in the upper reaches of the Yangtze River, the Chengdu-Chongqing economic circle is the most den...

Biocytogen Expands Global Footprint with the Opening of Biocyt...

BEIJING, March 28, 2022 /PRNewswire-Asianet/ -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (hereafter referred to as "Biocytogen") announced the opening of the Biocytogen Europe Innovati...

HCmed, Formosa Laboratories, and Formosa Pharmaceuticals Signe...

TAIPEI, Mar. 7, 2022 /PRNewswire-AsiaNet/-- HCmed Innovations, Co., Ltd. (HCmed) announced that it has formed a strategic alliance with Formosa Laboratories, Inc. (TPEx: 4746) and Formosa Ph...

Dr Charles Chen Yidan, Founder of Yidan Prize, Presents the Prestigious Award to Professor Usha Goswami at Cambridge University

Cambridge, UK, Mar 11, 2020 - (ACN Newswire) - Dr Charles Chen Yidan, founder of the Yidan Prize visited the United Kingdom this week to present the prestigious award to Professor Usha Gosw...

J L Stream launches a 'Made in India' Social LIVE streaming app

MUMBAI, India, March 3, 2021 /PRNewswire-AsiaNet/ -- With over 680 million active internet users and 450 million social network users, India has one of the lowest-priced data in the world. T...

Hitachi to Provide CNAO with Proton Therapy System

TOKYO, Dec 6, 2019 - (JCN Newswire) - Hitachi, Ltd. (TSE:6501) has entered into an agreement to provide Centro Nazionale di Adroterapia Oncologica (CNAO) with its proton therapy system.

image

Centro Nazionale di Adroterapia Oncologica (National Center for Oncological Hadrontherapy for the treatment of tumors)

In the comprehensive public tender process, Hitachi has been selected to provide proton therapy systems with the latest technologies including advanced scanning technology to irradiate even tumors with complex shapes with high precision.

The agreement includes multiyear service and maintenance of the system and this will be the 1st Hitachi Proton Therapy System to be installed in Italy and the 2nd in Europe.

CNAO, located in Pavia (near Milan), Italy, is a world's leading clinical center on particle cancer therapy and the first national hadrontherapy center in Italy. CNAO was established and is operated by the CNAO Foundation, a non-profit organization fully funded by the Italian government. CNAO has started cancer treatment for proton therapy since 2011 and heavy ion therapy since 2012, and it will develop a new proton therapy facility to enhance further research and cancer treatment.

Hitachi has been proactively promoting particle therapy system business worldwide, supplying world-class facilities with its highly reliable and proven particle therapy systems, which have treated more than 60,000 patients. Hitachi will provide system and services, including single room solution in realizing installation in urban limited areas and hybrid system combined with capability of generating both proton and heavy-ion in one accelerator, to meet all customer needs.

Hitachi will contribute to the improvement of people's quality of life and social values through the global expansion of its particle therapy system business.

About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, is focusing on Social Innovation Business combining its operational technology, information technology and products. The company's consolidated revenues for fiscal 2018 (ended March 31, 2019) totaled 9,480.6 billion yen ($85.4 billion), and the company has approximately 296,000 employees worldwide. Hitachi delivers digital solutions utilizing Lumada in five sectors including Mobility, Smart Life, Industry, Energy and IT, to increase our customer's social, environmental and economic value. For more information on Hitachi, please visit the company's website at https://www.hitachi.com.

Copyright 2019 JCN Newswire. All rights reserved. www.jcnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

Budaya politik tak tahu malu: Mengapa politikus bermasalah enggan mundur dari jabatannya?

Ahmad Sahroni saat memimpin Rapat Kerja Komisi III DPR RI.Fatimahalbar/Wikimedia Commons, CC BY● Meski bermasalah dan terlibat pidana, banyak politikus yang tidak mengundurkan diri dari jabatann...

Ibarat bom waktu di sawah: Mengapa pupuk dan pestisida bukan jawaban mengatasi dampak perubahan iklim

● Pupuk dan pestisida terbukti bisa menangkal efek perubahan iklim.● Namun fungsinya hanya sebagai ‘obat penghilang nyeri’ sesaat saja.● Tanpa perubahan kebijakan menuju ...

Bagaimana mencegah penyakit menular akibat banjir ketika pemerintah tak bisa diandalkan?

● Banjir meningkatkan risiko penyebaran penyakit menular pada manusia.● Bencana ini membawa kuman dan hewan pembawa penyakit lebih dekat dengan manusia, serta mengganggu sanitasi.● H...